ArticleJournal of global oncology2018
Decreasing Histology Turnaround Time Through Stepwise Innovation and Capacity Building in Rwanda.
Open access · goldAbstract read
In one paragraph
Article in Journal of global oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 16 citations in OpenAlex.
- Evaluating the current neuro-oncology capacity in Sub-Saharan Africa: A questionnaire-based survey.Neuro-oncology practice · 2026Article
- Factors Impeding the Timely Pathologic Diagnosis of Malignant Small Round Blue Cell Tumors in a Pediatric Tertiary Care Center in the Philippines: Identifying Opportunities to Optimize Pediatric Cancer Management.Asian Pacific journal of cancer prevention : APJCP · 2026Article
- Article
- Widefield frequency-domain autofluorescence lifetime imaging for detecting breast cancer in murine xenograft tumor tissues.Journal of biomedical optics · 2025Article
- Impact of functional electrical stimulation on nerve-damaged muscles by quantifying fat infiltration using deep learning.Scientific reports · 2024Article
- The role of telepathology in improving cancer diagnostic and research capacity in sub-Saharan Africa.Frontiers in medicine · 2022Article
- Utilization and predictors of postmastectomy radiation receipt in an Oncology Center in Zimbabwe.Breast cancer research and treatment · 2021Article
- Accuracy of Pathologic Diagnosis in Patients With Lymphoma and Survival: A Prospective Analysis From Botswana.JCO global oncology · 2021Article
- Strengthening Pathology Capacity to Deliver Quality Cancer Care in Cities in LMICs.JCO global oncology · 2021Article
- Treatment of Hodgkin Lymphoma With ABVD Chemotherapy in Rural Rwanda: A Model for Cancer Care Delivery Implementation.JCO global oncology · 2020Article
- Barriers to timely surgery for breast cancer in Rwanda.Surgery · 2019Article
- Dermatology-Driven Quality Improvement Interventions to Decrease Diagnostic Delays for Kaposi Sarcoma in Botswana.Journal of global oncology · 2019Article
- Telepathology in Low Resource African Settings.Frontiers in public health · 2019Article
- Pathology and cancer in Africa.Ecancermedicalscience · 2019Article
- Patient Characteristics, Early Outcomes, and Implementation Lessons of Cervical Cancer Treatment Services in Rural Rwanda.Journal of global oncology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors at 1 institution in 1 country.
Gaspard MuvugabigwiGaspard Muvugabigwi, Irenee Nshimiyimana, Emmanuel Hakizimana, Deo Ruhangaza, Origene Benewe, John Butonzi, and Tharcisse Mpunga, Butaro District Hospital, Ministry of Health, Butaro; Alexandra E. Fehr, Paul H. Park, Cyprien Shyirambere, Alexis Manirakiza, and Christian Rusangwa, Partners In Health/Inshuti Mu Buzima, Kigali, Rwanda; Lauren Greenberg and Kiran Bhai, Partners In Health; James R. Pepoon, Brigham and Women's Hospital, Boston, MA; Danny Milner, American Society for Clinical Pathology, Chicago, IL; and Lawrence N. Shulman, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Irenee NshimiyimanaGaspard Muvugabigwi, Irenee Nshimiyimana, Emmanuel Hakizimana, Deo Ruhangaza, Origene Benewe, John Butonzi, and Tharcisse Mpunga, Butaro District Hospital, Ministry of Health, Butaro; Alexandra E. Fehr, Paul H. Park, Cyprien Shyirambere, Alexis Manirakiza, and Christian Rusangwa, Partners In Health/Inshuti Mu Buzima, Kigali, Rwanda; Lauren Greenberg and Kiran Bhai, Partners In Health; James R. Pepoon, Brigham and Women's Hospital, Boston, MA; Danny Milner, American Society for Clinical Pathology, Chicago, IL; and Lawrence N. Shulman, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Lauren GreenbergGaspard Muvugabigwi, Irenee Nshimiyimana, Emmanuel Hakizimana, Deo Ruhangaza, Origene Benewe, John Butonzi, and Tharcisse Mpunga, Butaro District Hospital, Ministry of Health, Butaro; Alexandra E. Fehr, Paul H. Park, Cyprien Shyirambere, Alexis Manirakiza, and Christian Rusangwa, Partners In Health/Inshuti Mu Buzima, Kigali, Rwanda; Lauren Greenberg and Kiran Bhai, Partners In Health; James R. Pepoon, Brigham and Women's Hospital, Boston, MA; Danny Milner, American Society for Clinical Pathology, Chicago, IL; and Lawrence N. Shulman, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Emmanuel HakizimanaGaspard Muvugabigwi, Irenee Nshimiyimana, Emmanuel Hakizimana, Deo Ruhangaza, Origene Benewe, John Butonzi, and Tharcisse Mpunga, Butaro District Hospital, Ministry of Health, Butaro; Alexandra E. Fehr, Paul H. Park, Cyprien Shyirambere, Alexis Manirakiza, and Christian Rusangwa, Partners In Health/Inshuti Mu Buzima, Kigali, Rwanda; Lauren Greenberg and Kiran Bhai, Partners In Health; James R. Pepoon, Brigham and Women's Hospital, Boston, MA; Danny Milner, American Society for Clinical Pathology, Chicago, IL; and Lawrence N. Shulman, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Deo RuhangazaGaspard Muvugabigwi, Irenee Nshimiyimana, Emmanuel Hakizimana, Deo Ruhangaza, Origene Benewe, John Butonzi, and Tharcisse Mpunga, Butaro District Hospital, Ministry of Health, Butaro; Alexandra E. Fehr, Paul H. Park, Cyprien Shyirambere, Alexis Manirakiza, and Christian Rusangwa, Partners In Health/Inshuti Mu Buzima, Kigali, Rwanda; Lauren Greenberg and Kiran Bhai, Partners In Health; James R. Pepoon, Brigham and Women's Hospital, Boston, MA; Danny Milner, American Society for Clinical Pathology, Chicago, IL; and Lawrence N. Shulman, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Origene BeneweGaspard Muvugabigwi, Irenee Nshimiyimana, Emmanuel Hakizimana, Deo Ruhangaza, Origene Benewe, John Butonzi, and Tharcisse Mpunga, Butaro District Hospital, Ministry of Health, Butaro; Alexandra E. Fehr, Paul H. Park, Cyprien Shyirambere, Alexis Manirakiza, and Christian Rusangwa, Partners In Health/Inshuti Mu Buzima, Kigali, Rwanda; Lauren Greenberg and Kiran Bhai, Partners In Health; James R. Pepoon, Brigham and Women's Hospital, Boston, MA; Danny Milner, American Society for Clinical Pathology, Chicago, IL; and Lawrence N. Shulman, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Kiran BhaiGaspard Muvugabigwi, Irenee Nshimiyimana, Emmanuel Hakizimana, Deo Ruhangaza, Origene Benewe, John Butonzi, and Tharcisse Mpunga, Butaro District Hospital, Ministry of Health, Butaro; Alexandra E. Fehr, Paul H. Park, Cyprien Shyirambere, Alexis Manirakiza, and Christian Rusangwa, Partners In Health/Inshuti Mu Buzima, Kigali, Rwanda; Lauren Greenberg and Kiran Bhai, Partners In Health; James R. Pepoon, Brigham and Women's Hospital, Boston, MA; Danny Milner, American Society for Clinical Pathology, Chicago, IL; and Lawrence N. Shulman, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
James R PepoonGaspard Muvugabigwi, Irenee Nshimiyimana, Emmanuel Hakizimana, Deo Ruhangaza, Origene Benewe, John Butonzi, and Tharcisse Mpunga, Butaro District Hospital, Ministry of Health, Butaro; Alexandra E. Fehr, Paul H. Park, Cyprien Shyirambere, Alexis Manirakiza, and Christian Rusangwa, Partners In Health/Inshuti Mu Buzima, Kigali, Rwanda; Lauren Greenberg and Kiran Bhai, Partners In Health; James R. Pepoon, Brigham and Women's Hospital, Boston, MA; Danny Milner, American Society for Clinical Pathology, Chicago, IL; and Lawrence N. Shulman, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Alexandra E FehrGaspard Muvugabigwi, Irenee Nshimiyimana, Emmanuel Hakizimana, Deo Ruhangaza, Origene Benewe, John Butonzi, and Tharcisse Mpunga, Butaro District Hospital, Ministry of Health, Butaro; Alexandra E. Fehr, Paul H. Park, Cyprien Shyirambere, Alexis Manirakiza, and Christian Rusangwa, Partners In Health/Inshuti Mu Buzima, Kigali, Rwanda; Lauren Greenberg and Kiran Bhai, Partners In Health; James R. Pepoon, Brigham and Women's Hospital, Boston, MA; Danny Milner, American Society for Clinical Pathology, Chicago, IL; and Lawrence N. Shulman, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Paul H ParkGaspard Muvugabigwi, Irenee Nshimiyimana, Emmanuel Hakizimana, Deo Ruhangaza, Origene Benewe, John Butonzi, and Tharcisse Mpunga, Butaro District Hospital, Ministry of Health, Butaro; Alexandra E. Fehr, Paul H. Park, Cyprien Shyirambere, Alexis Manirakiza, and Christian Rusangwa, Partners In Health/Inshuti Mu Buzima, Kigali, Rwanda; Lauren Greenberg and Kiran Bhai, Partners In Health; James R. Pepoon, Brigham and Women's Hospital, Boston, MA; Danny Milner, American Society for Clinical Pathology, Chicago, IL; and Lawrence N. Shulman, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
John ButonziGaspard Muvugabigwi, Irenee Nshimiyimana, Emmanuel Hakizimana, Deo Ruhangaza, Origene Benewe, John Butonzi, and Tharcisse Mpunga, Butaro District Hospital, Ministry of Health, Butaro; Alexandra E. Fehr, Paul H. Park, Cyprien Shyirambere, Alexis Manirakiza, and Christian Rusangwa, Partners In Health/Inshuti Mu Buzima, Kigali, Rwanda; Lauren Greenberg and Kiran Bhai, Partners In Health; James R. Pepoon, Brigham and Women's Hospital, Boston, MA; Danny Milner, American Society for Clinical Pathology, Chicago, IL; and Lawrence N. Shulman, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Cyprien ShyirambereGaspard Muvugabigwi, Irenee Nshimiyimana, Emmanuel Hakizimana, Deo Ruhangaza, Origene Benewe, John Butonzi, and Tharcisse Mpunga, Butaro District Hospital, Ministry of Health, Butaro; Alexandra E. Fehr, Paul H. Park, Cyprien Shyirambere, Alexis Manirakiza, and Christian Rusangwa, Partners In Health/Inshuti Mu Buzima, Kigali, Rwanda; Lauren Greenberg and Kiran Bhai, Partners In Health; James R. Pepoon, Brigham and Women's Hospital, Boston, MA; Danny Milner, American Society for Clinical Pathology, Chicago, IL; and Lawrence N. Shulman, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Alexis ManirakizaGaspard Muvugabigwi, Irenee Nshimiyimana, Emmanuel Hakizimana, Deo Ruhangaza, Origene Benewe, John Butonzi, and Tharcisse Mpunga, Butaro District Hospital, Ministry of Health, Butaro; Alexandra E. Fehr, Paul H. Park, Cyprien Shyirambere, Alexis Manirakiza, and Christian Rusangwa, Partners In Health/Inshuti Mu Buzima, Kigali, Rwanda; Lauren Greenberg and Kiran Bhai, Partners In Health; James R. Pepoon, Brigham and Women's Hospital, Boston, MA; Danny Milner, American Society for Clinical Pathology, Chicago, IL; and Lawrence N. Shulman, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Christian RusangwaGaspard Muvugabigwi, Irenee Nshimiyimana, Emmanuel Hakizimana, Deo Ruhangaza, Origene Benewe, John Butonzi, and Tharcisse Mpunga, Butaro District Hospital, Ministry of Health, Butaro; Alexandra E. Fehr, Paul H. Park, Cyprien Shyirambere, Alexis Manirakiza, and Christian Rusangwa, Partners In Health/Inshuti Mu Buzima, Kigali, Rwanda; Lauren Greenberg and Kiran Bhai, Partners In Health; James R. Pepoon, Brigham and Women's Hospital, Boston, MA; Danny Milner, American Society for Clinical Pathology, Chicago, IL; and Lawrence N. Shulman, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Danny MilnerGaspard Muvugabigwi, Irenee Nshimiyimana, Emmanuel Hakizimana, Deo Ruhangaza, Origene Benewe, John Butonzi, and Tharcisse Mpunga, Butaro District Hospital, Ministry of Health, Butaro; Alexandra E. Fehr, Paul H. Park, Cyprien Shyirambere, Alexis Manirakiza, and Christian Rusangwa, Partners In Health/Inshuti Mu Buzima, Kigali, Rwanda; Lauren Greenberg and Kiran Bhai, Partners In Health; James R. Pepoon, Brigham and Women's Hospital, Boston, MA; Danny Milner, American Society for Clinical Pathology, Chicago, IL; and Lawrence N. Shulman, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Tharcisse MpungaGaspard Muvugabigwi, Irenee Nshimiyimana, Emmanuel Hakizimana, Deo Ruhangaza, Origene Benewe, John Butonzi, and Tharcisse Mpunga, Butaro District Hospital, Ministry of Health, Butaro; Alexandra E. Fehr, Paul H. Park, Cyprien Shyirambere, Alexis Manirakiza, and Christian Rusangwa, Partners In Health/Inshuti Mu Buzima, Kigali, Rwanda; Lauren Greenberg and Kiran Bhai, Partners In Health; James R. Pepoon, Brigham and Women's Hospital, Boston, MA; Danny Milner, American Society for Clinical Pathology, Chicago, IL; and Lawrence N. Shulman, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Lawrence N ShulmanGaspard Muvugabigwi, Irenee Nshimiyimana, Emmanuel Hakizimana, Deo Ruhangaza, Origene Benewe, John Butonzi, and Tharcisse Mpunga, Butaro District Hospital, Ministry of Health, Butaro; Alexandra E. Fehr, Paul H. Park, Cyprien Shyirambere, Alexis Manirakiza, and Christian Rusangwa, Partners In Health/Inshuti Mu Buzima, Kigali, Rwanda; Lauren Greenberg and Kiran Bhai, Partners In Health; James R. Pepoon, Brigham and Women's Hospital, Boston, MA; Danny Milner, American Society for Clinical Pathology, Chicago, IL; and Lawrence N. Shulman, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Partners In Health · US
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeMinimal turnaround time for pathology results is crucial for highest-quality patient care in all settings, especially in low- and middle-income countries, where rural populations may have limited access to health care.
methodsWe retrospectively determined the turnaround times (TATs) for anatomic pathology specimens, comparing three different modes of operation that occurred throughout the development and implementation of our pathology laboratory at the Butaro Cancer Center of Excellence in Rwanda. Before opening this laboratory, TAT was measured in months because of inconsistent laboratory operations and a paucity of in-country pathologists.
resultsWe analyzed 2,514 individual patient samples across the three modes of study. Diagnostic mode 1 (samples sent out of the country for analysis) had the highest median TAT, with an overall time of 30 days (interquartile range [IQR], 22 to 43 days). For diagnostic mode 2 (static image telepathology), the median TAT was 14 days (IQR, 7 to 27 days), and for diagnostic mode 3 (onsite expert diagnosis), it was 5 days (IQR, 2 to 9 days).
conclusionOur results demonstrate that telepathology is a significant improvement over external expert review and can greatly assist sites in improving their TATs until pathologists are on site.
Indexed as
Capacity BuildingHumansPathologyRetrospective StudiesRwanda
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.